As the biopharmaceutical industry accelerates its pursuit of groundbreaking therapies, the mammalian transient protein expression market emerges as a cornerstone for rapid, high-fidelity protein production. According to a new in-depth analysis by Future Market Insights (FMI), this dynamic sector is valued at USD 848.5 million in 2026 and is projected to reach USD 1,449.4 million by...